Key facts
- It has raised $1.8M; the latest was Early Stage VC ($1.8M) in Feb 2025.
- Notable investors include Blackbird Ventures, Jumpspace Ventures, Genesis Pre-Seed Fund.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Ultra Bionics
- ·The full record, as it builds
Funding rounds
No funding rounds for Ultra Bionics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Ultra Bionics
Developer of a brain-computer interface technology designed to restore lost neurological function in patients with severe motor and communication impairments. The company offers implantable neural devices that decode brain activity into digital commands, enabling individuals with conditions like paralysis and neurodegenerative diseases, improved autonomy and interaction with their environment.
- Sector
- Healthcare
- HQ
- Melbourne, Australia
- Founded
- 2024
- Employees
- 5
- Website
- ultra-bionics.com/
- Ownership
- Privately Held (backing)
Ultra Bionics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ultra Bionics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ultra Bionics in its N-PORT filings yet. We sweep new filings monthly.